Lantern Pharma Announces Publication Detailing Preclinical Results of Drug Candidate, LP-184, in a Spectrum of Drug-Resistant Lung Cancers in the Journal Oncotarget

Stock Information for Lantern Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.